The effect of paraprotein polymerisation on quantitation by capillary zone electrophoresis and Hevylite®. (November 2021)
- Record Type:
- Journal Article
- Title:
- The effect of paraprotein polymerisation on quantitation by capillary zone electrophoresis and Hevylite®. (November 2021)
- Main Title:
- The effect of paraprotein polymerisation on quantitation by capillary zone electrophoresis and Hevylite®
- Authors:
- Valentine, Helen
Dawnay, Anne - Abstract:
- Objectives: Up to 3% of patients with monoclonal gammopathies have multiple serum paraproteins. This article investigates whether multiple isotype-matched paraproteins, as seen on capillary zone electrophoresis, are truly biclonal. Methods: Serum samples containing multiple isotype-matched paraproteins were treated with the reducing agent dithiothreitol, and capillary zone electrophoresis was performed pre- and post-treatment. Band resolution and effect of resolution on quantitation of paraprotein burden were assessed. The Hevylite® turbidimetric assay was also evaluated for ability to quantify such paraproteins. Results: Among patients with biclonal isotype-matched paraproteins, 23/24 (96%) IgA paraproteins resolved into a single band following treatment with dithiothreitol compared with only 1/12 (8%) IgG paraproteins. Daratumumab therapy accounted for the second band in 5/9 non-resolving IgGκ paraproteins. Where initially quantified as a single IgA 'complex' (multiple bands in close proximity), the single postdithiothreitol band averaged 2.8 g/L less ( P <0.001), likely due to inclusion of lower amounts of underlying serum proteins (y = 0.97x–2.03, R 2 =0.993). Quantitating IgA biclonal isotype matched ( n = 58) using the Hevylite® assay gave higher results ( P = 0.002) than capillary zone electrophoresis (y = 1.48x–7.13, R 2 =0.959). In contrast, single IgA paraprotein results ( n = 48) did not differ between the two methods ( P = 0.466; y = 1.24x–2.74, R 2 =0.898),Objectives: Up to 3% of patients with monoclonal gammopathies have multiple serum paraproteins. This article investigates whether multiple isotype-matched paraproteins, as seen on capillary zone electrophoresis, are truly biclonal. Methods: Serum samples containing multiple isotype-matched paraproteins were treated with the reducing agent dithiothreitol, and capillary zone electrophoresis was performed pre- and post-treatment. Band resolution and effect of resolution on quantitation of paraprotein burden were assessed. The Hevylite® turbidimetric assay was also evaluated for ability to quantify such paraproteins. Results: Among patients with biclonal isotype-matched paraproteins, 23/24 (96%) IgA paraproteins resolved into a single band following treatment with dithiothreitol compared with only 1/12 (8%) IgG paraproteins. Daratumumab therapy accounted for the second band in 5/9 non-resolving IgGκ paraproteins. Where initially quantified as a single IgA 'complex' (multiple bands in close proximity), the single postdithiothreitol band averaged 2.8 g/L less ( P <0.001), likely due to inclusion of lower amounts of underlying serum proteins (y = 0.97x–2.03, R 2 =0.993). Quantitating IgA biclonal isotype matched ( n = 58) using the Hevylite® assay gave higher results ( P = 0.002) than capillary zone electrophoresis (y = 1.48x–7.13, R 2 =0.959). In contrast, single IgA paraprotein results ( n = 48) did not differ between the two methods ( P = 0.466; y = 1.24x–2.74, R 2 =0.898), suggesting that polymerisation enhances Hevylite® quantitation. Conclusions: These results suggest that disulphide-mediated polymerisation of IgA paraproteins is more common than true biclonal gammopathy and support dithiothreitol treatment of samples with isotype-matched IgA bands before quantifying by capillary zone electrophoresis. The Hevylite® assay should be utilized with caution where polymerisation is likely. Where IgGκ biclonal isotype-matched paraproteins appear on capillary zone electrophoresis, daratumumab therapy should be considered. … (more)
- Is Part Of:
- Annals of clinical biochemistry. Volume 58:Number 6(2021)
- Journal:
- Annals of clinical biochemistry
- Issue:
- Volume 58:Number 6(2021)
- Issue Display:
- Volume 58, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 58
- Issue:
- 6
- Issue Sort Value:
- 2021-0058-0006-0000
- Page Start:
- 586
- Page End:
- 592
- Publication Date:
- 2021-11
- Subjects:
- Proteins -- tumour markers -- electrophoresis
Clinical chemistry -- Periodicals
Clinical biochemistry -- Periodicals
616.075 - Journal URLs:
- http://web.ebscohost.com/ehost/detail?sid=810a7788-77dd-439f-9630-ad7f5b199fd3%40sessionmgr4&vid=1&hid=14&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=mnh&jid=0324055 ↗
http://acb.rsmjournals.com ↗
http://www.usc.edu/hsc/nml/e-resources/info/annclib.html ↗
http://www.uk.sagepub.com/home.nav ↗
http://www.ingentaconnect.com/content/rsm/acb ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1177/00045632211029327 ↗
- Languages:
- English
- ISSNs:
- 0004-5632
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25033.xml